Sie befinden sich hier: Mitarbeiter > publist

Prof. Dr. Jürgen Harder
Aktuelle Publikationen


2017

Keine Einträge

2016

Bierkarre H, Harder J, Cuthbert R, Emery P, Leuschner I Mrowietz U, Hedderich J, McGonagle D, Gläser R
Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity
Scand J Rheumatol 2016;45(3):188-96
Harder J
Tick saliva: Paving the way for the stowaway borrelia.
Exp. Dermatol. 2016;25:20-21
Bayer A, Lammel J, Rademacher F, Groß J, Siggelkow M, Lippross S, Klüter T, Varoga D, Tohidnezhad M, Pufe T, Cremer J, Gläser R, Harder J.
Platelet-released growth factors induce the antimicrobial peptide human beta-defensin-2 in primary keratinocytes.
Exp Dermatol. 2016;Epub ahead of print
Simanski M, Rademacher F, Schröder L, Gläser R, Harder J.
The Inflammasome and the Epidermal Growth Factor Receptor (EGFR) Are Involved in the Staphylococcus aureus-Mediated Induction of IL-1alpha and IL-1beta in Human Keratinocytes.
PLoS One 2016;Jan 25;11(1):e0147118
Rademacher F, Simanski M, Harder J.
RNase 7 in Cutaneous Defense.
Int J Mol Sci. 2016;14 April 2016; 17(4): e560
Manz J, Rodríguez E, ElSharawy A, Oesau EM, Petersen BS, Baurecht H, Mayr G, Weber S, Harder J, Reischl E, Schwarz A, Novak N, Franke A, Weidinger S
Targeted Resequencing and Functional Testing Identifies Low-Frequency Missense Variants in the Gene Encoding GARP as Significant Contributors to Atopic Dermatitis Risk
J Invest Dermatol 2016;[Epub ahead of print]

2015

Schaarschmidt H, Ellinghaus D, Rodríguez E, Kretschmer A, Baurecht H, Lipinski S, Meyer-Hoffert U, Harder J, Lieb W, Novak N, Fölster-Holst R, Esparza-Gordillo J, Marenholz I, Ruschendorf F, Hubner N, Reischl E, Waldenberger M, Gieger C, Illig T, Kabesch M, Zhang XJ, Xiao FL, Lee YA, Franke A, Weidinger S
A genome-wide association study reveals 2 new susceptibility loci for atopic dermatitis
J Allergy Clin Immunol. 2015;136(3):802-6
Amatngalim GD, van Wijck Y, de Mooij-Eijk Y, Verhoosel RM, Harder J, Lekkerkerker AN, Janssen RA, Hiemstra PS
Basal Cells Contribute to Innate Immunity of the Airway Epithelium through Production of the Antimicrobial Protein RNase 7
Journal of Immunology 2015;194(7):3340-50

2014

Roth SA, Simanski M, Rademacher F, Schröder L, Harder J.
The pattern recognition receptor NOD2 mediates Staphylococcus aureus-induced IL 17C expression in keratinocytes
J Invest Dermatol 2014;134(2):374-80
Cordes J, Wittersheim M, Harder J, Gläser R
The skin's own antibiotics : Important features of antimicrobial peptides for clinical practice.
Hautarzt 2014;65(1):50-55
Steinz K, Schubert S, Harder J, Gerdes S, Mrowietz U, Gläser R.
Bacterial soft tissue infection in psoriasis despite induction of epidermal antimicrobial peptides.
Exp. Dermatol. 2014;23(11):862-4
Simanski M, Gläser R, Harder J
Human skin engages different epidermal layers to provide distinct innate defense mechanisms.
Exp Dermatol 2014;23(4):230-231
Rodríguez E, Baurecht H, Wahn AF, Kretschmer A, Hotze M, Zeilinger S, Klopp N, Illig T, Schramm K, Prokisch H, Gieger C, Harder J, Cifuentes L, Novak N, Weidinger S
An integrated epigenetic and transcriptomic analysis reveals distinct patterns of DNA methylation associated with atopic dermatitis.
Journal of Investigative Dermatology 2014;134(7):1873-83
Firat HF, Simanski M, Rademacher F, Schröder L, Brasch J, Harder J
Infection of keratinocytes with Trichophyton rubrum induces epidermal growth factor-dependent RNase 7 and human beta-defensin-3 expression.
PLOS ONE 2014;9(4):e93941
Gläser R, Becker K, von Eiff C, Meyer-Hoffert U, Harder J
Decreased susceptibility of Staphylococcus aureus small colony variants (SCVs) towards human antimicrobial peptides
Journal of Investigative Dermatology 2014;134(9):2347-50

2013

Harder J, Schröder JM, Gläser R
The skin surface as antimicrobial barrier: present concepts and future outlooks.
Exp. Dermatol. 2013;22:1-5
Simanski M, Rademacher F, Schröder L, Gläser R, Harder J
IL-17A and IFN-gamma synergistically induce RNase 7 expression via STAT3 in primary keratinocytes.
PLOS ONE 2013;8(3):e59531
Simanski M, Gläser R, Köten B, Meyer-Hoffert U, Wanner S, Weidenmaier C, Peschel A, Harder J
Staphylococcus aureus subverts cutaneous defense by D-alanylation of teichoic acids.
Exp Derm 2013;22(4):294-296
Wittersheim M, Cordes J, Meyer-Hoffert U, Harder J, Hedderich J, Gläser R
Differential Expression and in vivo Secretion of the Antimicrobial Peptides Psoriasin (S100A7), RNase 7, human beta-Defensin-2 and -3 in Healthy Human Skin.
Exp Derm 2013;22(5):264-366
Schuster C, Gläser R, Fiala C, Eppel W, Harder J, Schröder JM, Elbe-Bürger A
Prenatal human skin expresses the antimicrobial peptide Rnase 7
Arch Derm Res 2013;305(6):545.549
Harder J, Tsuruta D, Murakami M, Kurokawa I
What is the role of antimicrobial peptides (AMP) in acne vulgaris?
Exp Dermatol 2013;22(6):386-391
Kopfnagel V, Harder J, Werfel T
Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions
Curr Opin Allergy Clin Immunol. 2013;13(5):531-536
Lichtenberger BM, Gerber PA, Holcmann M, Buhren BA, Amberg N, Smolle V, Schrumpf H, Boelke E, Ansari P, Mackenzie C, Wollenberg A, Kislat A, Fischer JW, Röck K, Harder J, Schröder JM, Homey B, Sibilia M
Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation.
Science TM 2013;21;5(199):199ra111

2012

Köten B, Becker K, Podschun R, von Eiff C, Meyer-Hoffert U, Harder J, Gläser R
Susceptibility of Staphylococcus aureus bacteremia strains to different skin-derived antimicrobial proteins.
Arch Dermatol Res 2012;304(8):633-7
Simanski M, Köten B, Schröder JM, Gläser R, Harder J
Antimicrobial Rnases in cutaneous defense.
J Innate Immun. 2012;4(3):241-7
Simanski M, Babucke S, Eberl L, Harder J
Paraoxonase 2 acts as a quorum sensing-quenching factor in human keratinocytes.
J Invest Dermatol 2012;132(9):2296-9

2011

Laudien M, Dressel S, Harder J, Gläser R
Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion
Rhinology 2011;49(1):107-11
Gläser R, Meyer-Hoffert U, Harder J
Staphylokokken
Fortschritte der praktischen Dermatologie und Venerologie 2010 (Hrsg.Ruzicka, Th.; Wolff, H.; Thomas, P.; Prinz) 2011;S 242-246
Harder J, Gläser R
Abwehr und Entzündung – Antimikrobielle Proteine als Infektionsschutz
Fortschritte der praktischen Dermatologie und Venerologie 2010 (Hrsg.Ruzicka, Th.; Wolff, H.; Thomas, P.; Prinz, J.) 2011;S 531-542
Gläser R, Köten B, Wittersheim M, Harder J
Psoriasin: key molecule of the cutaneous barrier?
J Dtsch Dermatol Ges 2011;Epub Apr 19
Garreis F, Gottschalt M, Schlorf T, Gläser R, Harder J, Worlitzsch D, Paulsen FP
Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus
Invest Ophthalmol Vis Sci 2011;Epub May 6
Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Göß C, Anz D, Simanski M, Gläser R, Harder J, Hornung V, Gallo RL, Ruzicka T, Besch R, Schauber J
Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions
Sci Transl Med 2011;Epub May 11
Jensen JM, Ahrens K, Mengassner J, Scherer A, Bräutigam M, Stütz A, Schwarz T, Fölster-Holst R, Harder J, Gläser R, Proksch E
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids
Exp Dermatol 2011;Epub June 24
Ahrens K, Schunck M, Podda GF, Meingassner J, Stuetz A, Schröder JM, Harder J, Proksch E.
Mechanical and metabolic injury to the skin barrier leads to increased expression of murine ?-defensin-1, -3, and -14.
J Invest Dermatol. 2011;131(2):443-52

2010

Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Fölster-Holst R, Proksch E, Schröder JM, Schwarz T, Gläser R
Enhanced expression an secretion of antimicrobial peptides in atopic dermatitis an after superficial skin injury
J Invest Dermatol 2010;130(5):1355-64
Dressel s, Harder J, Cordes J, Wittersheim M, Meyer-Hoffert U, Sunderkötter C, Gläser R
Differential expression of antimicrobial peptides in margins of chronic wounds
Exp Dermatol 2010;Exp Dermatol 19(7):628-32
Simanski M, Dressel S, Gläser R, Harder J.
RNase 7 Protects Healthy Skin from Staphylococcus aureus Colonization.
J Invest Dermatol. 2010;130(12):2836-8
Himmerkus N, Vassen V, Sievers B, Goerke B, Shan Q, Harder J, Schröder JM, Bleich M.
Human beta-defensin-2 increases cholinergic response in colon epithelium.
Pflugers Arch 2010;460(1):177-186

2009

Gläser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J, Fölster-Holst R, Proksch E, Schröder JM, Schwarz T
The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption.
J Invest Dermatol. 2009;129(3):641-9
Bosch TC, Augustin R, Anton-Erxleben F, Fraune S, Hemmrich G, Zill H, Rosenstiel P, Jacobs G, Schreiber S, Leippe M, Stanisak M, Grötzinger J, Jung S, Podschun R, Bartels J, Harder J, Schröder JM.
Uncovering the evolutionary history of innate immunity: the simple metazoan Hydra uses epithelial cells for host defence.
Dev Comp Immunol 2009;33(4):559-69
Abtin A, Eckhart L, Mildner M, Ghannadan M, Harder J, Schröder JM, Tschachler E.
Degradation by Stratum Corneum Proteases Prevents Endogenous RNase Inhibitor from Blocking Antimicrobial Activities of RNase 5 and RNase 7.
J Invest Dermatol 2009;im Druck
Harder J, Núñez G.
Functional Expression of the Intracellular Pattern Recognition Receptor NOD1 in Human Keratinocytes.
J Invest Dermatol 2009;im Druck
Wu Z, Meyer-Hoffert U, Reithmayer K, Paus R, Hansmann B, He Y, Bartels J, Gläser R, Harder J, Schröder JM.
Highly Complex Peptide Aggregates of the S100 Fused-Type Protein Hornerin Are Present in Human Skin.
J Invest Dermatol 2009;129(6):1446-58
Dressel S, Harder J, Gläser R
Antimikrobielle Peptide der Haut
Haut 2009;6: 223-225
Gläser R, Meyer-Hoffert U, Harder J.
Antimicrobial peptides in atopic dermatitis. A paradigm shift?
Hautarzt 2009;60(9):761-2
Gläser R*, Navid F*, Schuller W, Jantschitsch C, Harder J, Schröder JM, Schwarz A, Schwarz T.
UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo.
J Allergy Clin Immunol 2009;123(5):1117-23
Reithmayer K, Meyer KC, Kleditzsch P, Tiede S, Uppalapati SK, Gläser R, Harder J, Schröder JM, Paus R
Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7.
BRIT J DERMATOL. 2009;161(1):78-89
Köten B, Simanski M, Gläser R, Podschun R, Schröder JM, Harder J.
RNase 7 contributes to the cutaneous defense against Enterococcus faecium.
PLoS One. 2009;4(7):e6424.
Harder J, Franchi L, Munoz-Planillo R, Park JH, Reimer T, Nunez G
Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLP signaling and P2X7 receptor.
J Immunol. 2009;183(3):5823-9

2008

Hinrichsen K, Podschun R, Schubert S, Schröder JM, Harder J*, Proksch E       *Co-Seniorautor und Corresponding-Author
Mouse beta-defensin-14 (mBD-14/defb14): An antimicrobial ortholog of human beta-defensin-3 (hBD-3/ DEFB103A)
Antimicrob Agents Chemother 2008;52(5):1876-9
Meyer JE, Harder J*, Sipos B, Maune S, Klöppel G, Bartels J, Schröder JM, Gläser R       *Co-Erstautor
Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongue.
Mucosal Immunol 2008;1(3):239-243.
Harder J
Antimicrobial peptides: Ancient molecules as modern therapeutics?
Expert Review of Dermatology 2008;3(1):1-5
Schlee M, Harder J, Köten B, Stange EF, Wehkamp J, Fellermann K
Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2.
Clin Exp Immunol 2008;151(3):528-35.
Suttmann H, Retz M, Paulsen F, Harder J, Zwergel U, Kamradt J, Wullich B, Unteregger G, Stöckle M, Lehmann J.
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells.
BMC Urol 2008;8:5
Harder J, Proksch E
Antimicrobial proteins: Innate effectors of cutaneus defense.
Kératin 2008;15:15-23
Eigenbrod T, Park JH, Harder J, Iwakura Y, Núñez G.
Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells.
J Immunol 2008;181(12):8194-8

2007

Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Glaser R
Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours
J Cancer Res Clin Oncol 2007;133(4):253-61
Harder J, Gläser R, Schröder JM.
The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases.
Endocr Metab Immune Disord Drug Targets 2007;7(2):75-82.
Harder J, Gläser R, Schröder JM
Human antimicrobial proteins effectors of innate immunity.
J Endotoxin Res. 2007;13(6): 317-38
Meyer JE, Harder J.
Antimicrobial peptides in oral cancer
Curr Pharm Des 2007;13(30):3119-30
Gläser R, Harder J, Schröder JM
Antimicrobial Peptides as First-Line Effector Molecules of the Human Innate Immune System.
Nucleic Acids and Molecular Biology 2007;21:187-218
Schroeder JM, Glaeser R, Harder J
Antimicrobial Peptides: Effector molecules of the cutaneus defense system.
In: Molecular Biology and Pharmacology of Tissue Repair, ed. S. Werner, International Congress Series 1302. 2007;26-35
Gläser R, Harder J, Schröder J-M
Antimicrobial Peptides as First-Line Effector Molecules of the Human Innate Immune System.
In: Innate Immunity of Plants, Animals and Humans. Eds.: H.Heine, Springer Verlag Berlin Heidelberg New York . 2007;Chapter 9: 187-218

2006

Rudolph B, Podschun R, Sahly H, Schubert S, Schröder JM, Harder J
Identification of RNase 8 as a novel human antimicrobial protein
Identification of RNase 8 as a novel human antimicrobial protein 2006;50:3194-3196
Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, Paulsen F, Harder J, Unteregger G, Stockle M
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines
Eur Urol 2006;50:141-147
Bohling A, Hagge SO, Roes S, Podschun R, Sahly H, Harder J, Schröder JM, Grotzinger J, Seydel U, Gutsmann T
Lipid-specific membrane activity of human beta-defensin-3
Biochemistry 2006;45(17):5663-5670
Sahly H, Schubert S, Harder J, Kleine M, Sandvang D, Ullmann U, Schröder JM, Podschun R
Activity of human beta-defensins 2 and 3 against ESBL-producing Klebsiella strains
J Antimicrob Chemother 2006;57(3):562-565
Schröder JM, Harder J
Innate antimicrobial peptides in the skin
Med Sci (Paris) 2006;22(2):153-157
Schröder JM, Harder J
Antimicrobial skin peptides and proteins
Cell Mol Life Sci 2006;63(4):469-486
Voss E, Wehkamp J, Wehkamp K, Stange EF, Schröder JM, Harder J
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2
J Biol Chem 2006;281(4):2005-2011
Wehkamp K, Schwichtenberg L, Schröder JM, Harder J
Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1
J Invest Dermatol 2006;126(1):121-127
Schroeder JM, Harder J
Antimicrobial Peptides in skin disease.
DRUG DISCOVERY TODAY:Therapeutic Strategies 2006;3(1): 93-100
Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, Paulsen F, Harder J, Unteregger G, Stockle M.
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
Eur.Urol. 2006;50:141-147

2005

Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection
NATURE IMMUNOLOGY 2005;6:57-64
Harder J, Schröder JM
Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins.
JOURNAL OF LEUKOCYTE BIOLOGY 2005;77:476-486
Harder J, Schröder JM
Antimicrobial peptides in human skin.
CHEMICAL IMMUNOLOGY  2005;86:22-41
Varoga D, Pufe T, Harder J, Schroder JM, Mentlein R, Meyer-Hoffert U, Goldring MB, Tillmann B, Hassenpflug J, Paulsen F.
Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors.
ARTHRITIS AND RHEUMATISM 2005;52:1736-1745
Kiehne K, Brunke G, Meyer D, Harder J, Herzig KH.
Oesophageal defensin expression during Candida infection and reflux disease.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY  2005;40:501-507
Varoga D, Pufe T, Harder J, Schröder JM, Mentlein R, Meyer-Hoffert U, Goldring MB, Tillmann B, Hassenpflug J, Paulsen F.
Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors.
Arthritis Rheum 2005;52(6):1736-45

2004

Varoga D, Pufe T, Harder J, Meyer-Hoffert U, Mentlein R, Schroder JM, Petersen WJ, Tillmann BN, Proksch E, Goldring MB, Paulsen FP
Production of endogenous antibiotics in articular cartilage
ARTHRITIS AND RHEUMATISM 2004;50:3526-3534
Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM
Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2004;123:522-529
Meyer JE, Harder J, Gorogh T, Weise JB, Schubert S, Janssen D, Maune S
Human beta-defensin-2 in oral cancer with opportunistic Candida infection
ANTICANCER RESEARCH 2004;24:1025-1030
Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, Schroder JM, Bevins CL, Fellermann K, Stange EF
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
GUT 2004;53:1658-1664
Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schroder JM, Stange EF
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic
INFECTION AND IMMUNITY 2004;72:5750-5758

2003

Sahly H, Schubert S, Harder J, Rautenberg P, Ullmann U, Schroder J, Podschun R
Burkholderia is highly resistant to human Beta-defensin 3.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2003;47:1739-1741
Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K, Schroeder JM and Stange EF
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.
INFLAMMATORY BOWEL DISEASES 2003;9:215-223

2002

Harder, J., Schröder, J.M.
RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin.
JOURNAL OF BIOLOGICAL CHEMISTRY 2002;277:4677-4678
Lehmann, J., Retz, M., Harder, J., Krams, M., Kellner, U., Hartmann, J., Hohgrawe, K., Raffenberg, U., Gerber, M., Loch, T., Weichert-Jacobsen, K., Stöckle, M.
Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection.
BMC Infect Dis 2002;2:20-21

Zurück

Aktuelles:

 

Praktikum der Dermatologie

Das Hauptpraktikum Dermatologie beginnt am 17.10.2017 um 7:45 mit einer Einführungsvorlesung im Hörsaal der Hautklinik.  [mehr]

 


Dermatologie für Zahnmediziner

Die Veranstaltung beginnt am 24.10.2017  um 10:00 c.t. im Hörsaal der Hautklinik.


Lehrpreis 2017

Der Preis der Medizinischen Fakultät für die beste Lehre geht in diesem Jahr erneut an die Hautklinik  [mehr]


Neurodermitis Präventionsstudie

Studie zur frühkindlichen Anwendung von Hautpflegecremes [mehr]


Regulation von Botenstoffen der Entzündung

Kieler Team des Exzellenzclusters Entzündungsforschung deckt grundlegend neuen Mechanismus au. [mehr]


Prof. Fölster-Holst neue Präsidentin der ESPD

Professorin Dr. Regina Fölster-Holst, Klinik für Dermatologie, Venerologie und Allergologie, Medizinische Fakultät der Christian-Albrechts-Universität zu Kiel ist neue Präsidentin der Europäischen Gesellschaft für Kinderdermatologie (European Society for Pediatric Dermatology, ESPD). [mehr]


Patientenleitlinie zum Melanom erschienen

Der umfangreiche Ratgeber gibt in allgemeinverständlicher Sprache alle Empfehlungen zu Untersuchungen und Behandlungen wieder, die zuvor für die ärztliche Leitlinie zum Melanom erarbeitet worden sind.

Die Druckfassung zum kostenlosen Download [hier]   

 

Die Seite wurde zuletzt am 16.11.2017 um 11:51 geändert.